4TT7: Crystal Structure Of Human Alk With A Covalent Modification reference: Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787., Parker AR, Petluru PN, Nienaber VL, Zhao M, Ayala PY, Badger J, Chie-Leon B, Sridhar V, Logan C, Kochat H, Hausheer FH, Onco Targets Ther. 2015 Feb 4;8:375-83. doi: 10.2147/OTT.S73690. eCollection, 2015. PMID: 25678804 |
This OCA
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).